Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.
Autor: | Lerner A; Chaim Sheba Medical Center, The Zabludowicz Research Center for Autoimmune Diseases, Tel Hashomer, Israel., Sobolevskaia P; Saint Petersburg State University, St. Petersburg, Russia., Churilov L; Saint Petersburg State University, St. Petersburg, Russia., Shoenfeld Y; Chaim Sheba Medical Center, The Zabludowicz Research Center for Autoimmune Diseases, Tel Hashomer, Israel.; Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Visiting Professor), Moscow, Russia.; Ariel University, Ariel, Israel. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of translational autoimmunity [J Transl Autoimmun] 2021 Jun 16; Vol. 4, pp. 100109. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021). |
DOI: | 10.1016/j.jtauto.2021.100109 |
Abstrakt: | Celiac disease is a life-long intestinal autoimmune disease, characterized by the gluten intolerance and chronic enteric inflammation. Traditionally presented by intestinal manifestations, however, a shift toward extra intestinal presentation is taking place. One of the affected organs is the nervous systems presented by neuropsychiatric manifestations, hence the mechanism and pathways are not clear. The presence of neuronal and alpha-enolases and their corresponding antibodies were noticed in the mucosa and serum of celiac disease patients, as well as in other various autoimmune diseases with psycho-neurological manifestations. The aims of the present review are to screen the literature on different isoforms of enolase, mainly alpha enolase, and their specific antibodies and to suggest their potential pathophysiological mechanisms relaying the enolases to intestinal or extraintestinal celiac disease manifestations. The shared aspects between the enolases and celiac disease and the cross-talks between alpha-enolase and tissue transglutaminase suggest new potential pathophysiological mechanisms that might drive celiac disease evolvement. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2021 The Authors. Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |